These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 15628355)

  • 1. [Urinary trypsinogen activation peptide (TAP)].
    Naruse S
    Nihon Rinsho; 2004 Nov; 62 Suppl 11():131-2. PubMed ID: 15628355
    [No Abstract]   [Full Text] [Related]  

  • 2. Early prediction of severe acute pancreatitis by urinary trypsinogen activation peptide.
    Liu ZS; Jiang CQ; Qian Q; Sun Q; Fan LF; Ai ZL
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):285-9. PubMed ID: 14612286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary trypsinogen activation peptide is more accurate than hematocrit in determining severity in patients with acute pancreatitis: a prospective study.
    Khan Z; Vlodov J; Horovitz J; Jose RM; Iswara K; Smotkin J; Brown A; Tenner S
    Am J Gastroenterol; 2002 Aug; 97(8):1973-7. PubMed ID: 12190163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis.
    Johnson CD; Lempinen M; Imrie CW; Puolakkainen P; Kemppainen E; Carter R; McKay C
    Br J Surg; 2004 Aug; 91(8):1027-33. PubMed ID: 15286966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the urinary trypsinogen-2, trypsinogen activation peptide, and the computed tomography severity index as early predictors of the severity of acute pancreatitis.
    Huang QL; Qian ZX; Li H
    Hepatogastroenterology; 2010; 57(102-103):1295-9. PubMed ID: 21410075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and urine concentrations of trypsinogen-activation peptide as markers for acute pancreatitis in cats.
    Allen HS; Steiner J; Broussard J; Mansfield C; Williams DA; Jones B
    Can J Vet Res; 2006 Oct; 70(4):313-6. PubMed ID: 17042387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary trypsinogen activation peptides (TAP) are not increased in mild ERCP-induced pancreatitis.
    Banks PA; Carr-Locke DL; Slivka A; Van Dam J; Lichtenstein DR; Hughes M
    Pancreas; 1996 Apr; 12(3):294-7. PubMed ID: 8830337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of immunoreactive trypsinogen activation peptide in urine in acute pancreatitis.
    Petersson U; Borgström A
    JOP; 2006 May; 7(3):274-82. PubMed ID: 16685108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of urinary trypsinogen-2 and trypsinogen activation peptide in acute pancreatitis: A multicenter study in Japan.
    Yasuda H; Kataoka K; Takeyama Y; Takeda K; Ito T; Mayumi T; Isaji S; Mine T; Kitagawa M; Kiriyama S; Sakagami J; Masamune A; Inui K; Hirano K; Akashi R; Yokoe M; Sogame Y; Okazaki K; Morioka C; Kihara Y; Kawa S; Tanaka M; Andoh A; Kimura W; Nishimori I; Furuse J; Yokota I; Shimosegawa T
    World J Gastroenterol; 2019 Jan; 25(1):107-117. PubMed ID: 30643362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypsinogen activation peptide in acute pancreatitis.
    Frossard JL
    Lancet; 2000 Aug; 356(9231):766-7. PubMed ID: 11085712
    [No Abstract]   [Full Text] [Related]  

  • 11. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis.
    Tenner S; Fernandez-del Castillo C; Warshaw A; Steinberg W; Hermon-Taylor J; Valenzuela JE; Hariri M; Hughes M; Banks PA
    Int J Pancreatol; 1997 Apr; 21(2):105-10. PubMed ID: 9209951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism and role of trypsinogen activation in acute pancreatitis.
    Mayer J; Rau B; Schoenberg MH; Beger HG
    Hepatogastroenterology; 1999; 46(29):2757-63. PubMed ID: 10576341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay of trypsinogen activation in the cat experimental model of acute pancreatitis.
    Karanjia ND; Widdison AL; Jehanli A; Hermon-Taylor J; Reber HA
    Pancreas; 1993 Mar; 8(2):189-95. PubMed ID: 8460094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What are the predictors of post-ERCP pancreatitis, and how useful are they?
    Sultan S; Baillie J
    JOP; 2002 Nov; 3(6):188-94. PubMed ID: 12432185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone affects inflammation but not trypsinogen activation in experimental acute pancreatitis.
    Muller CA; Belyaev O; Appelros S; Buchler M; Uhl W; Borgstrom A
    Eur Surg Res; 2008; 40(4):317-24. PubMed ID: 18303267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Trypsinogen activation peptides in acute pancreatitis. Experimental data and clinical implications].
    Foitzik T; Fernandez-del Castillo C; Lewandrowski KB; Rattner DW; Herfarth C; Warshaw AL
    Chirurg; 1994 Mar; 65(3):186-9. PubMed ID: 8194402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial protease activation is the central event in progression to necrotizing pancreatitis.
    Fernández-del Castillo C; Schmidt J; Warshaw AL; Rattner DW
    Surgery; 1994 Sep; 116(3):497-504. PubMed ID: 8079180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for extraluminal trypsinogen activation in three different models of acute pancreatitis.
    Foitzik T; Lewandrowski KB; Fernández-del Castillo C; Rattner DW; Warshaw AL
    Surgery; 1994 Jun; 115(6):698-702. PubMed ID: 8197561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypsin activation peptide (TAP) in acute pancreatitis: from pathophysiology to clinical usefulness.
    Frossard JL
    JOP; 2001 Mar; 2(2):69-77. PubMed ID: 11867866
    [No Abstract]   [Full Text] [Related]  

  • 20. CAPAP in acute pancreatitis: just another marker or real progress?
    Büchler MW; Uhl W; Andrén-Sandberg A
    Gut; 1998 Jan; 42(1):8-9. PubMed ID: 9505874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.